Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?
Preprints.org January 24, 2019 preprint DOI: 10.20944/preprints201901.0249.v1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review |
|---|---|
| Keywords | Psychopharmacology Psychotherapist Mental health |
| Citations | 8 |
| Key findings | Psychedelic drugs represent a promising and integrative treatment with enduring effects for mental health problems. |
Abstract
The current crisis in psychopharmacology has a long history and needs to be addressed with innovative and effective strategies. Here we discuss some of the roots of this crisis and suggest that the therapeutic use of psychedelic drugs represents a promising and integrative treatment with enduring effects for mental health problems.
Citations in the library
Cited by 5
- Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users Journal of Psychoactive Drugs February 7, 2019
- Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology Current Medicinal Chemistry December 13, 2019
- Psychedelic Medicines in Major Depression: Progress and Future Challenges. Advances in experimental medicine and biology 2021
- The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review Journal of Psychopharmacology June 26, 2026
- Exploring the regulatory framework of psychedelics in the US & Europe. Asian Journal of Psychiatry December 1, 2024
Cites 33
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
and 28 more in the library